BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castelli R, Lambertenghi Delilliers G, Gidaro A, Cicardi M, Bergamaschini L. Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course. Clin Exp Immunol 2020;201:258-65. [PMID: 32515487 DOI: 10.1111/cei.13475] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Bienz M, Morin-Ben Abdallah S, Greenaway C, Pelletier JS, Caplan S, Knecht H. Severe Cystic Echinococcosis-Associated Immune Thrombocytopenic Purpura: A Case Report. J Hematol 2021;10:71-5. [PMID: 34007368 DOI: 10.14740/jh789] [Reference Citation Analysis]
2 Castelli R, Gidaro A, Lambertenghi Deliliers G. Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures. Blood Coagul Fibrinolysis 2021;32:163-6. [PMID: 33555693 DOI: 10.1097/MBC.0000000000001001] [Reference Citation Analysis]
3 Audia S, Bonnotte B. Emerging Therapies in Immune Thrombocytopenia. J Clin Med 2021;10:1004. [PMID: 33801294 DOI: 10.3390/jcm10051004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Audia S, Mahévas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B. Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments. Hemasphere 2021;5:e574. [PMID: 34095758 DOI: 10.1097/HS9.0000000000000574] [Reference Citation Analysis]
5 Ramírez-López A, Álvarez Román MT, Monzón Manzano E, Acuña P, Arias-Salgado EG, Martín Salces M, Rivas Pollmar MI, Jiménez Yuste V, Justo Sanz R, García Barcenilla S, Cebanu T, González Zorrilla E, Butta NV. The Importance of Platelet Glycoside Residues in the Haemostasis of Patients with Immune Thrombocytopaenia. J Clin Med 2021;10:1661. [PMID: 33924503 DOI: 10.3390/jcm10081661] [Reference Citation Analysis]
6 Mingot-castellano ME, Bastida JM, Caballero-navarro G, Entrena Ureña L, González-lópez TJ, González-porras JR, Butta N, Canaro M, Jiménez-bárcenas R, Gómez del Castillo Solano MDC, Sánchez-gonzález B, Pascual-izquierdo C; on behalf of the GEPTI. Novel Therapies to Address Unmet Needs in ITP. Pharmaceuticals 2022;15:779. [DOI: 10.3390/ph15070779] [Reference Citation Analysis]
7 Getawa S, Aynalem M, Bayleyegn B, Adane T. The global prevalence of thrombocytopenia among HIV-infected adults: A systematic review and meta-analysis. Int J Infect Dis 2021;105:495-504. [PMID: 33684556 DOI: 10.1016/j.ijid.2021.02.118] [Reference Citation Analysis]